Main Content
Welcome
Triveritas provides comprehensive product development, clinical study and regulatory affairs services to the animal health industry with offices in UK, USA, Canada, Germany and France.
——————-
Triveritas joins Cyton Biosciences as part of the knoell group
Find out more in our news section >>
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
To find out more, including how to control cookies, see here: Cookie Policy
History
Since the year 2000 the company has expanded from 3 to over 30 staff operating in the UK, USA, Canada, Germany, France and Poland.
Triveritas’ growth can be attributed to commitment, knowledge,
expertise and flexibility.
Projects are tailored to match individual client needs particularly in the areas of animal GCP trials, regulatory affairs,
project management and Quality Assurance.
Concept to marketing approval
The phrase “one-stop-shop” has become a bit of a cliché. But that is exactly what Triveritas can offer, taking projects through the early proof of concept stage to final international approval.
At Triveritas strategic regulatory advice goes hand in hand with effective project planning and expertise across all development areas to steer a product through the vital development stages as swiftly and efficiently as possible.
At Triveritas strategic regulatory advice goes hand in hand with effective project planning and expertise across all development areas to steer a product through the vital development stages as swiftly and efficiently as possible.
Triveritas Group
Triveritas has over 40 staff worldwide, including veterinarians and scientists.